IL162509A0 - Use of deoxypeganine for treating clinical depression - Google Patents
Use of deoxypeganine for treating clinical depressionInfo
- Publication number
- IL162509A0 IL162509A0 IL16250902A IL16250902A IL162509A0 IL 162509 A0 IL162509 A0 IL 162509A0 IL 16250902 A IL16250902 A IL 16250902A IL 16250902 A IL16250902 A IL 16250902A IL 162509 A0 IL162509 A0 IL 162509A0
- Authority
- IL
- Israel
- Prior art keywords
- deoxypeganine
- clinical depression
- treating clinical
- treating
- depression
- Prior art date
Links
- WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 title 2
- VARHXCYGZKSOOO-UHFFFAOYSA-N Deoxyvasicinone Natural products C1=CC=C2C(=O)N(CCC3)C3=NC2=C1 VARHXCYGZKSOOO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10163667A DE10163667B4 (de) | 2001-12-21 | 2001-12-21 | Verwendung von Desoxypeganin zur Behandlung der klinischen Depression |
| PCT/EP2002/014274 WO2003053445A1 (de) | 2001-12-21 | 2002-12-14 | Verwendung von desoxypeganin zur behandlung der klinischen depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL162509A0 true IL162509A0 (en) | 2005-11-20 |
Family
ID=7710660
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16250902A IL162509A0 (en) | 2001-12-21 | 2002-12-14 | Use of deoxypeganine for treating clinical depression |
| IL162509A IL162509A (en) | 2001-12-21 | 2004-06-14 | Use of deoxypeganine for the production of a drug for treating clinical depression |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL162509A IL162509A (en) | 2001-12-21 | 2004-06-14 | Use of deoxypeganine for the production of a drug for treating clinical depression |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20050009813A1 (uk) |
| EP (1) | EP1461042B1 (uk) |
| JP (1) | JP2005513105A (uk) |
| KR (1) | KR100614504B1 (uk) |
| CN (1) | CN1283253C (uk) |
| AR (1) | AR037967A1 (uk) |
| AT (1) | ATE404203T1 (uk) |
| AU (1) | AU2002363874B2 (uk) |
| BR (1) | BR0215306A (uk) |
| CA (1) | CA2471338C (uk) |
| CZ (1) | CZ301210B6 (uk) |
| DE (2) | DE10163667B4 (uk) |
| DK (1) | DK1461042T3 (uk) |
| EA (1) | EA006896B1 (uk) |
| ES (1) | ES2312657T3 (uk) |
| HK (1) | HK1066742A1 (uk) |
| HU (1) | HUP0402298A3 (uk) |
| IL (2) | IL162509A0 (uk) |
| MX (1) | MXPA04006125A (uk) |
| MY (1) | MY138088A (uk) |
| NO (1) | NO326446B1 (uk) |
| NZ (1) | NZ533249A (uk) |
| PL (1) | PL370315A1 (uk) |
| PT (1) | PT1461042E (uk) |
| SI (1) | SI1461042T1 (uk) |
| SK (1) | SK287152B6 (uk) |
| TW (1) | TWI241189B (uk) |
| UA (1) | UA76254C2 (uk) |
| WO (1) | WO2003053445A1 (uk) |
| ZA (1) | ZA200404053B (uk) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE521512C2 (sv) * | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
| ES2285233T3 (es) | 2002-12-20 | 2007-11-16 | Niconovum Ab | Un material en particulas que contiene nicotina y celulosa microcristalina fisicamente y quimicamente estable. |
| DE10354894A1 (de) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
| DE10354893B4 (de) * | 2003-11-24 | 2011-03-10 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
| FR2865650B1 (fr) * | 2004-01-30 | 2008-06-13 | Biocortech | Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil |
| JP5000932B2 (ja) * | 2005-06-21 | 2012-08-15 | 日東電工株式会社 | ニコチン含有経皮吸収製剤 |
| WO2007104573A2 (en) | 2006-03-16 | 2007-09-20 | Niconovum Ab | Improved snuff composition |
| CN101433565B (zh) * | 2008-11-26 | 2013-06-05 | 上海中医药大学 | 骆驼蓬属种子总生物碱提取物和它们的制备 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19906975B4 (de) * | 1999-02-19 | 2004-04-15 | Lts Lohmann Therapie-Systeme Ag | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
| DE19906979B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
| DE19906974C2 (de) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Verwendung von Desoxypeganin zur Behandlung des Alkoholismus |
| DE19906977C1 (de) * | 1999-02-19 | 2000-06-15 | Lohmann Therapie Syst Lts | Desoxypeganin-TTS und seine Verwendung |
| DE19906978B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit |
-
2001
- 2001-12-21 DE DE10163667A patent/DE10163667B4/de not_active Expired - Fee Related
-
2002
- 2002-12-12 MY MYPI20024665A patent/MY138088A/en unknown
- 2002-12-14 EP EP02798337A patent/EP1461042B1/de not_active Expired - Lifetime
- 2002-12-14 AT AT02798337T patent/ATE404203T1/de active
- 2002-12-14 PL PL02370315A patent/PL370315A1/xx not_active Application Discontinuation
- 2002-12-14 UA UA20040604815A patent/UA76254C2/uk unknown
- 2002-12-14 CN CNB028254031A patent/CN1283253C/zh not_active Expired - Fee Related
- 2002-12-14 MX MXPA04006125A patent/MXPA04006125A/es active IP Right Grant
- 2002-12-14 ES ES02798337T patent/ES2312657T3/es not_active Expired - Lifetime
- 2002-12-14 IL IL16250902A patent/IL162509A0/xx unknown
- 2002-12-14 US US10/496,366 patent/US20050009813A1/en not_active Abandoned
- 2002-12-14 EA EA200400751A patent/EA006896B1/ru not_active IP Right Cessation
- 2002-12-14 DK DK02798337T patent/DK1461042T3/da active
- 2002-12-14 SI SI200230755T patent/SI1461042T1/sl unknown
- 2002-12-14 BR BR0215306-8A patent/BR0215306A/pt not_active Application Discontinuation
- 2002-12-14 CZ CZ20040739A patent/CZ301210B6/cs not_active IP Right Cessation
- 2002-12-14 CA CA002471338A patent/CA2471338C/en not_active Expired - Fee Related
- 2002-12-14 HU HU0402298A patent/HUP0402298A3/hu unknown
- 2002-12-14 NZ NZ533249A patent/NZ533249A/en not_active IP Right Cessation
- 2002-12-14 KR KR1020047009851A patent/KR100614504B1/ko not_active IP Right Cessation
- 2002-12-14 SK SK258-2004A patent/SK287152B6/sk not_active IP Right Cessation
- 2002-12-14 PT PT02798337T patent/PT1461042E/pt unknown
- 2002-12-14 DE DE50212649T patent/DE50212649D1/de not_active Expired - Lifetime
- 2002-12-14 JP JP2003554202A patent/JP2005513105A/ja not_active Ceased
- 2002-12-14 WO PCT/EP2002/014274 patent/WO2003053445A1/de active IP Right Grant
- 2002-12-14 AU AU2002363874A patent/AU2002363874B2/en not_active Ceased
- 2002-12-17 TW TW091136439A patent/TWI241189B/zh not_active IP Right Cessation
- 2002-12-20 AR ARP020105056A patent/AR037967A1/es unknown
-
2004
- 2004-05-25 ZA ZA200404053A patent/ZA200404053B/en unknown
- 2004-06-14 IL IL162509A patent/IL162509A/en not_active IP Right Cessation
- 2004-06-14 NO NO20042476A patent/NO326446B1/no not_active IP Right Cessation
- 2004-12-14 HK HK04109919A patent/HK1066742A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL159344A0 (en) | Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease | |
| GB2393202B (en) | Methods of well treatment | |
| IL160884A0 (en) | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease | |
| EP1416961A4 (en) | COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE | |
| HK1091840A1 (en) | Methods and compositions for therapeutic use of rna interference | |
| EP1390029A4 (en) | PHENYLINDOLES FOR THE TREATMENT OF HIV INFECTION | |
| IL158251A0 (en) | Treatment of collagen | |
| GB0121155D0 (en) | Treatment of substrates | |
| EP1368024A4 (en) | TREATMENT OF RESTENOSIS | |
| HUP0400024A2 (hu) | Neoplasztikus betegségek kezelésére szolgáló gyógyszerkombinációk | |
| HUP0500734A3 (en) | Use of 2-alkoxyphenyl-substituted imidazotriazinones | |
| IL162509A0 (en) | Use of deoxypeganine for treating clinical depression | |
| GB0124124D0 (en) | Methods of treatment | |
| IL161748A0 (en) | New use for the treatment of gastroesophageal reflux | |
| IL188485A0 (en) | New use of iloperidone | |
| GB0113910D0 (en) | Treatment of liquids | |
| EP1435962A4 (en) | TREATMENT OF DIABETES TYPE I | |
| GB0101146D0 (en) | Treatment of skin conditions | |
| IL149705A0 (en) | Combination treatment for depression and anxiety | |
| IL161630A0 (en) | Methods of treating endometreosis | |
| IL158413A0 (en) | Treatment of adhd | |
| GB0100092D0 (en) | Treatment of degenerative diseases | |
| AU2002367463A8 (en) | Novel p53bp2 compounds for therapy and diagnosis and methods for using same | |
| GB0120654D0 (en) | Treatment of anemia | |
| HU0104370D0 (en) | Honeyed schnaps of oerseg |